One Touch Portable Digital Handheld 3 in 1 Blood Lipids Tc Tg Hdl Function Biochemical Analysis Meter

Name: One Touch Portable Digital Handheld 3 in 1 Blood Lipids Tc Tg Hdl Function Biochemical Analysis Meter
Brand: Hangzhou Soy MedTech Co., Ltd.
SKU: 1918539982

Zhejiang, ChinaHangzhou Soy MedTech Co., Ltd.

US$120.00-180.00

1 Piece

Product profile

Customized

Type

Human Health Analyzer

Group

Middle-aged and Old

Model NO.

LPM-101

Certification

Methodology

Reflectance Photometer

Specimen

Whole Blood(Capillary and Venous )

Power Source

AAA Battery

Battery Endurance

Approximately 1,000 Tests

Units of Measurement

Mmol/L, Mg/Dl

Automatic Shut off

5 Minutes After Displaying Results

Warranty Period

2 Years

Meter Shelf Life

4 Years

Test Strip Shelf Life

1 Years

Test Time

120 Seconds

Transport Package

34.5*32.6*24cm

Specification

TC:2.59-12.93 ; HDL:0.39-2.59 ;TG:0.51-7.34 mmol/L

Trademark

Lysun

Production Capacity

50000

Company profile

Hangzhou Soy MedTech Co., Ltd.Zhejiang, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2019-04-22Nearest Port: Shanghai, NingboAverage Response Time: ≤6.51hTerms of Payment: LC, T/T, PayPal, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, CIP

AI-Powered supplier vetting

SummarySoyMed is identified as a trading company focused on medical diagnosis products and related technical services, with a licensed scope covering third-class medical device operations. It reports ISO 13485 and ISO 9001 certifications, a Hangzhou factory location, 11–20 years of combined R&D engineer experience, 6–10 quality-control staff, and stated rapid-test and POCT meter output. The supplier demonstrates several customization options, but the assessment data states no 3D software design service, no ODM service, no SDK availability, and no new products during the past year. Service-management controls are weakly documented: no written procedures or records were provided for supplier assessment, corrective and preventive actions, or complaint handling. It also reports no inventory, overseas warehouse, overseas showroom, or overseas agents/branches. Financial records are referenced for recent years, but the slices do not provide financial results sufficient to assess credibility. No customer cases are provided.

Supplier typeThe supplier is explicitly classified as a Trading Company. Its stated scope includes technical services and technology development, while its product scope is Medical Diagnosis and its licensed activities include third-class medical device operation.

CertificationsThe supplier explicitly reports holding ISO 13485 and ISO 9001 certifications. These certifications support its medical-device quality-management positioning, although no certificate numbers, validity dates, or scope details are provided.

After-Sales capabilityThe supplier states that it has no inventory, overseas warehouse, overseas showroom, or overseas agents/branches. It also has no written procedures or records for effective complaint handling, indicating a documented after-sales service deficiency.

R&D capabilityInnovation evidence is limited: the supplier reports no new products in the past year, no ODM service, no SDK availability, and zero national science and technology progress awards. It does report 11–20 years of total R&D engineer experience, but the explicit limitations outweigh this as evidence of current innovation strength.

Production capacityThe supplier reports a factory location in Hangzhou, 6–10 quality-control staff, and annual output information of 10,000,000 rapid-test and POCT meter pieces. These stated production and quality resources provide explicit evidence of production capability.

Customization capabilityThe supplier’s R&D capability information lists customization from samples, full customization, customization from designs, flexible customization, and minor customization. However, the same assessment states that 3D software design services and ODM services are unavailable, while the company description claims OEM and ODM availability; this creates a direct inconsistency, so only the listed customization modes can be treated as supported.